Back to Journals
Blood and Lymphatic Cancer: Targets and Therapy
Dr Wilson Gonsalves
Dr. Wilson Gonsalves is an assistant professor of Medicine at Mayo Clinic in the Division of Hematology. He completed his medical school and internal medicine residency at Creighton University School of Medicine and his fellowship training in hematology/oncology as well as an advanced fellowship in dysproteinemias at the Mayo Clinic. His clinical practice focuses on the management of patients with plasma cell disorders such as multiple myeloma, light chain amyloidosis etc. His translational research focuses on understanding the cellular metabolism of malignant plasma cells in diseases such as multiple myeloma by employing a variety of systems biology techniques in an integrated fashion. He is also interested in enhancing the supportive care of patients with plasma cell disorders by incorporating clinical interventions to improve symptoms and quality of life. He also studies population-based outcomes in various plasma cell. Dr. Gonsalves leads several investigator-initiated early phase clinical trials evaluating novel therapeutics in plasma cell disorders. Finally, he has authored an co-authored several publications on clinical and translational research in plasma cell disorders. He serves on the editorial board for several other peer-reviewed journals as well as a reviewer with an expertise in plasma cell disorders for several journals.
Federico Caligaris-Cappio, Professor of Internal Medicine, Chair of Internal Medicine and Head, Division of Internal Medicine; Head, Department of Oncology, Università Vita-Salute San Raffaele, Milano, Italy
Preet M Chaudhary, Professor, Department of Medicine, Ron Bloom Endowed Chair in Lymphoma, University of Southern California; Chief, Jane Ann Nohl Division of Hematology and Center for the Study of Blood Diseases, Los Angeles, CA, USA
Prof. Dr. Huang
Wenya Huang, Professor, Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University Medical College, Tainan; Consultant, Molecular Diagnosis, Pathology, National Cheng Kung University Hospital, Tainan, Taiwan
Joseph McGuirk, Professor of Medicine, Schutte-Speas Professor of Hematology-Oncology; Division Director, Hematologic Malignancies and Cellular Therapeutics; Medical Director, Blood and Marrow Transplant, Department of Internal Medicine, The University of Kansas Health System, Cancer Center and Medical Pavilion, Westwood, KS, USA
Amitkumar Mehta, Assistant Professor, Lymphoma Program, Hematology and Oncology, University of Alabama at Birmingham, AL, USA.
Prof. Alessandro Morotti, Professor of Internal Medicine, Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy.
Mariano Provencio, Professor of Medicine, Oncology Department, Hospital Universitario Puerta de Hierro, University of Madrid, Madrid, Spain
Giuseppe Saglio, Professor of Hematology, University of Turin; Director of the Department of Clinical and Biological Sciences of the University of Torino; Director, Hematology Division, Ospedale Mauriziano, Torino, Italy
SM Singh, Professor & Coordinator, Tumor Immunology, Faculty of Science, School of Biotechnology, Banaras Hindu University, Varanasi, India
Chaitra Ujjani, MD, Associate Professor, Fred Hutchinson Cancer Center, Division of Medical Oncology, University of Washington, Washington, DC, USA.
Masaki Yasukawa, Professor and Chairman, Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine; Chief of Center, Reproductive Medicine, Ehime University, Toon, Ehime, Japan
Prof. Dr. Zhao
Zhao Jinhua, Professor, Director, Dept. of Nuclear Medicine, The First People's Hospital, Shanghai Jiaotong University, Shanghai, People's Republic of China